Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.17
+0.19 (1.73%)
At close: Nov 21, 2025, 4:00 PM EST
11.13
-0.04 (-0.36%)
Pre-market: Nov 24, 2025, 7:00 AM EST
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $971.99 million as of November 24, 2025. Its market cap has decreased by -28.91% in one year.
Market Cap
971.99M
Enterprise Value
441.79M
1-Year Change
-28.91%
Ranking
Category
Stock Price
$11.17
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $971.99M, an increase of 754.87%. That is a compound annual growth rate of 23.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 972.00M | 43.51% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |